Newsroom

Industry veterans Nathaniel "Ned" David, PhD, and Norman "Ned" Sharpless, MD, have launched Jupiter Bioventures, a biotechnology venture foundry aimed at transforming novel science into impactful companies. With the support of multiple new backers, including the CU Healthcare Innovation Fund, the venture plans to advance eight to ten companies focused on developing cancer therapeutics and other related treatments.

RefinedScience, a biosciences company, moved to Fitzsimons Innovation Community from CU Innovations. They use advanced data analysis to speed up drug development, leveraging unique datasets from CU and UCHealth. Initially a clinical tool, they’ve evolved into a precision medicine platform. Their new location supports growth and access to top talent, aiding their expansion into new research areas.

In his annual State of the Campus Address, Chancellor Donald Elliman reflected on a year of remarkable achievements and a future of hope. From record-breaking research numbers and life-changing innovations to the incredible energy and spirit of our community, #CUAnschutz has transformed into a world-class hub where dreams come to life — a place to drive discovery, a place to inspire hope.

The University of Colorado system is a hub of innovation, supporting startups through extensive accelerator programs that provide legal, patent, and financial assistance. This support has significantly boosted the state’s economic growth and technological advancements. The article showcases the university’s success in fostering groundbreaking research and impactful health solutions, underscoring its role as a national leader in startup creation and technological innovation.

iRhythm Technologies has partnered with BioIntelliSense to enhance its cardiac monitoring platform with advanced sensor technology. This collaboration aims to improve continuous patient monitoring and expand iRhythm's reach into areas like sleep apnea, boosting patient outcomes and healthcare efficiency.

Fitzsimons Innovation Community and CU Innovations partner to advance healthcare by connecting startups with the University of Colorado Anschutz Medical Campus. Dr. Gali Baler emphasizes engagement between companies and campus, in addition to programs like SPARK and the Startup Foundry, which provide funding, resources, and mentorship, driving impactful innovations in patient care.

Q32 Bio’s innovative approach to targeting the complement system could revolutionize treatments for various diseases. If successful, their research may provide a “skeleton key” to address a wide array of health conditions.

CU Innovations proudly unveils its newly redesigned website featuring the Sophia Inventor Portal. As part of our ongoing commitment to providing innovators with the best experience, we have enhanced our online platform to improve usability, navigation and save you time!